Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending September 30, 2023 was $130 Million (a -7.26% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments decreased by -27.83%
- Annual Cash and Short Term Investments for 2022 was $179 Million (a -31.79% decrease from previous year)
- Annual Cash and Short Term Investments for 2021 was $263 Million (a 276.55% increase from previous year)
- Annual Cash and Short Term Investments for 2020 was $69.9 Million (a 433.91% increase from previous year)
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Absci Corporation
Most recent Cash and Short Term Investmentsof ABSI including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Absci Corporation
Absci Corporation Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $129.51 | $139.65 | $159.29 | – | – |
| 2022 | $179.45 | $196.33 | $221.04 | $249.02 | $179.45 |
| 2021 | $263.08 | $289.77 | $109.95 | $180.76 | $263.08 |
| 2020 | – | – | – | $69.87 | $69.87 |
| 2019 | $13.09 | – | – | – | $13.09 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology